Reports
Reports
Sale
The global ophthalmoscopes market size was valued at USD 253.69 million in 2023, driven by the rising number of global research and development activities. The market size is anticipated to grow at a CAGR of 5.5% during the forecast period of 2024-2032 to achieve a value of USD 411.74 million by 2032.
Ophthalmoscope is a device that enables the investigation of the back of the eye to look at the health of the retina, optic nerve, vasculature, and vitreous humor. This exam produces an upright image of approximately 15 times magnification. The large aperture is used for a dilated pupil after administering mydriatic drops.
The growth of the market is supported by the increasing development in the ophthalmoscope sector. The increasing advancements to improve the efficacy and overall performance of ophthalmoscopes with additional features are contributing significantly to the market growth. For example, a new multicolour video-ophthalmoscope has been developed lately, which is based on the existing mono-colour video-ophthalmoscope that allows healthcare professionals to measure the spectral distribution of light absorption of blood in the human retina with the use of narrow-band transmission filters. Such developments are expected to propel the global ophthalmoscope market growth.
In October 2023, Baxter International Inc., one of the leading companies in patient monitoring, physical assessment, and vision screening products, announced the launch of digital image capture capability, for eye examination with the use of their Welch AllynPanOptic Plus Ophthalmoscope. The iExaminer Pro System adds a key technology to routine eye examinations, designed to help advance healthcare professionals’ ability to examine and diagnose the eye health of patients. Such innovations are set to not only enhance patient outcomes but provide convenience to healthcare professionals, propelling the market growth further.
Market Breakup by Product Type
Market Breakup by Light Source
Market Breakup by Application
Market Breakup by End User
Market Breakup by Region
The market growth is significantly driven by factors such as growing geriatric population, due to which the prevalence of eye diseases is also increasing. The continuous advancements in technology are also driving the market growth further. For instance, according to a WHO report published in 2022, nearly 2.2 billion of the population was suffering from near or distant vision impairment worldwide. The leading cause of this vision impairment in geriatric population is often considered to be age-related macular degeneration, glaucoma, and diabetic retinopathy.
The adaptation of sedentary lifestyle by people has also collectively resulted in the increased incidence of various diseases leading to visual impairment, such as diabetes and hypertension. All these factors are substantially driving the ophthalmoscopes market demand. Due to the increased incidence of eye diseases, there has been a considerable rise in the number of ophthalmic procedures being performed, enhancing the demand for ophthalmoscopes devices, further propelling the market growth.
Geographically, North America has been dominating the global ophthalmoscopes market share and is expected to dominate for the forecast period as well. The regional growth is influenced by increasing prevalence of eye diseases and disorders, such as diabetic retinopathy, age-related macular degeneration, and glaucoma requiring regular eye examination behaving as a primary factor driving the market growth of the ophthalmoscopes. For instance, according to an article published by the brain focus foundation earlier this year nearly 20 million American adults are suffering from age-related macular degeneration (AMD).
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product Type |
|
Breakup by Light Source |
|
Breakup by Application |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Ophthalmoscopes Market Overview
3.1 Global Ophthalmoscopes Market Historical Value (2017-2023)
3.2 Global Ophthalmoscopes Market Forecast Value (2024-2032)
4 Global Ophthalmoscopes Market Landscape
4.1 Global Ophthalmoscopes Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Ophthalmoscopes Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Light Source
4.2.3 Analysis by Application
5 Global Ophthalmoscopes Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Ophthalmoscopes Market Segmentation
6.1 Global Ophthalmoscopes Market by Product Type
6.1.1 Market Overview
6.1.2 Direct Ophthalmoscopes
6.1.3 Indirect Ophthalmoscopes
6.2 Global Ophthalmoscopes Market by Light Source
6.2.1 Market Overview
6.2.2 Halogen Illumination Ophthalmoscopes
6.2.3 Xenon Illumination Ophthalmoscopes
6.2.4 LED Illumination Ophthalmoscopes
6.3 Global Ophthalmoscopes Market by Application
6.3.1 Market Overview
6.3.2 Glaucoma
6.3.3 Retinal Diseases
6.3.4 Diabetes Eye Diseases
6.3.5 Others
6.4 Global Ophthalmoscopes Market by End User
6.4.1 Market Overview
6.4.2 Hospitals
6.4.3 Speciality Clinics
6.4.4 Eye Institutes
6.4.5 Ambulatory Surgical Centres
6.4.6 Others
6.5 Global Ophthalmoscopes Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Ophthalmoscopes Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Ophthalmoscopes Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Ophthalmoscopes Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Ophthalmoscopes Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Ophthalmoscopes Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Welch Allyn
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Zumax Medical Co. Ltd
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Keeler Ltd. Co.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Neitz Instruments Co., Ltd.
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Albert Waeschle
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Heine USA Ltd.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 HONSUN Group
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Rudolf Riester GmbH
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 US Ophthalmic
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Dino-Lite Europe
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 GlobalMed
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Carl Zeiss Meditec AG
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
18 Global Ophthalmoscopes Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The market attained a value of about USD 253.69 million in 2023, driven by the increasing development of the healthcare sector.
The market is anticipated to grow at a CAGR of 5.5% during the forecast period of 2024-2032 and is likely to reach a market value of USD 411.74 million by 2032.
The increasing cases of ophthalmic diseases, along with the increasing geriatric population, are among major factors driving the market growth.
The continuous development and innovation to enhance the efficiency of the ophthalmoscopes is a major trend influencing the market growth.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.
Different types of ophthalmoscopes include direct ophthalmoscopes and indirect ophthalmoscopes.
There are various light sources for ophthalmoscopes such as halogen illumination ophthalmoscopes, xenon illumination ophthalmoscopes, and LED illumination ophthalmoscopes.
They find wide applications in glaucoma, retinal diseases, and diabetes eye diseases, among others.
End users in the market are hospitals, speciality clinics, eye institutes, and ambulatory surgical centres, among others.
Key players involved in the market are Welch Allyn, Zumax Medical Co., Ltd., Keeler Ltd. Co., Neitz Instruments Co., Ltd., Albert Waeschle, Heine USA Ltd, HONSUN Group, Rudolf Riester GmbH, US Ophthalmic, Dino-Lite Europe, GlobalMed, and Carl Zeiss Meditec AG.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.